MARKET RADAR
SENSEX     NIFTY      Refresh
You are here : MONEYCONTROL > MARKETS > SHARE PRICE > PHARMACEUTICALS > COMPANY INFO - KILITCH DRUGS (INDIA)

Kilitch Drugs (India)

BSE: 524500 | NSE: KILITCH | ISIN: INE729D01010 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
May 22, 17:00
21.90
0.15 (+0.69%)
VOLUME 2,353
AVERAGE VOLUME
5-Day 3,325
10-Day 4,112
30-Day 3,616
VOLUME SHOCKER
5-Day 3,325
10-Day 4,112
30-Day 3,616
Prev. Close
21.75
Open Price
21.50
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 21.35 22.00
52 Wk Low/High 19.50 90.45
LIVE
NSE
May 22, 17:00
21.75
0.30 (+1.40%)
VOLUME 6,250
AVERAGE VOLUME
5-Day 5,961
10-Day 6,119
30-Day 5,062
VOLUME SHOCKER
5-Day 5,961
10-Day 6,119
30-Day 5,062
Prev. Close
21.45
Open Price
21.45
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 21.10 22.00
52 Wk Low/High 19.80 90.50
MARKET CAP (Rs Cr)
28.98
*P/E
0.35
*BOOK VALUE (Rs)
87.49
DIV (%)
300.00%
Market Lot
1
INDUSTRY P/E
27.94
*EPS (TTM)
62.56
*P/C
0.33
*PRICE/BOOK
0.25
DIV YIELD.(%)
136.99%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
68.27 new
DELIVERY AVERAGES
3-Day 62.03%
5-Day 67.26%
8-Day 68.99%
* Based on standalone numbers
Track Kilitch Drugs on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 30-May-2013 (Audited Results)
EXPAND ALL COLLAPSE ALL
Would you bet on Kilitch Drugs today?
Test your strategy with virtual money on Moneybhai
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 44.00 21.50  
High Price 44.00 22.00  
Low Price 38.10 21.35  
Last Price 39.20 21.90 -44.13
Volume 19,275 2,353 -87.79
Simple Moving Averages
Days BSE NSE
30 21.80 21.73
50 21.90 21.91
150 30.36 30.48
200 38.55 38.69

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Kilitch Drugs

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
  (Dec '12)
Quarterly
(Mar '12)
Yearly
Net Sales 3.45 106.82
Other Income 2.07 1.09
PBDIT 0.96 10.44
Net Profit 0.63 88.62

Annual Report

Download in PDF format 2011 |2010
Balance Sheet
(Mar '12)
(In Rs Cr)
Total Share Capital 13.23
Net Worth 115.77
Total Debt 8.77
Net Block 8.47
Investments 140.18
Net Current Assets -24.12
Total Assets 124.53
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 1001.90 2.90 1013.10 569.00 103,754.96
Dr Reddys Labs 2056.55 1.84 2150.90 1555.00 34,927.72
Lupin 768.50 -0.05 810.80 519.00 34,400.91
Cipla 415.25 -0.44 435.00 305.00 33,341.31
GlaxoSmithKline 2277.45 0.07 2522.00 2005.00 19,290.69
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Dec' 12Sep' 12Jun' 12Mar' 12
Promoter64.4364.4364.4364.43
FII0.000.000.000.00
DII0.010.010.010.01
Others35.5635.5635.5635.56
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
C-301/2, MIDC, TTC Industrial area,,Pawane Village
City
Thane
State
Maharashtra
Pin Code
400705
Tel. No.
022-27670322 022-27680913
Fax No.
022-27680912
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C-13, Pannalal Silk Mill Compound, LBS Marg, Bhandup (West)
City
Mumbai - 400078
State
Maharashtra
Tel. No.
022-25960320
Fax No.
022-25960329
MANAGEMENT
Name
Designation
Mukund P Mehta
Managing Director
Paresh P Mehta
Joint Managing Director
Neelima A Waigankar
Whole Time Director
Bhavin M Mehta
Executive Director
Mukesh Shah
Independent Director
Message Board & Community
Quick Links for Kilitch Drugs India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.